Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,110 JPY | -0.78% | -3.77% | -0.58% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company is one of the best yield companies with high dividend expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- With a 2024 P/E ratio at 22.27 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.58% | 1.14B | - | ||
-1.35% | 242B | B- | ||
+8.16% | 18.57B | B+ | ||
0.00% | 16.6B | - | - | |
-4.59% | 10.49B | A- | ||
-11.11% | 9.88B | A- | ||
+1.03% | 6.53B | B+ | ||
+4.08% | 5.67B | B | ||
-4.74% | 4.22B | B+ | ||
-13.95% | 3.97B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4928 Stock
- Ratings Noevir Holdings Co., Ltd.